Stocktoria
Pennant Group, Inc. PNTG
Pennant Group, Inc. (PNTG) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the grey zone. It pays a dividend yielding 0.93% (safety: no dividend). FY2025 revenue was $947.7M at a 3.1% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.021 |
| Retained earnings / assets | 0.09 |
| EBIT / assets | 0.054 |
| Equity / liabilities | 0.63 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| PNTG | Pennant Group, Inc. | 3/9 | 1.45 | 42.2 | +36.3% |
| INNV | InnovAge Holding Corp. | 6/9 | 0.08 | — | +11.8% |
| USPH | U S PHYSICAL THERAPY INC /NV | 6/9 | 2.26 | 25.5 | +16.3% |
| LFST | LifeStance Health Group, Inc. | 7/9 | 1.7 | 412.6 | +13.9% |
| PIII | P3 Health Partners Inc. | 2/9 | -10.32 | — | -2.8% |
| WGS | GeneDx Holdings Corp. | 6/9 | -5.22 | — | +40% |
| DCGO | DocGo Inc. | 4/9 | -4.05 | — | -47.7% |
About Pennant Group, Inc.
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities in Alabama, Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin, and Wyoming. The Company was incorporated in 2019 and is headquartered in Eagle, Idaho.
FAQ
Is PNTG financially healthy?
Pennant Group, Inc.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does PNTG pay a dividend, and is it safe?
Yes. Pennant Group, Inc. pays a dividend yielding about 0.93% with a None payout ratio, rated “no dividend” for safety.
How profitable is PNTG?
In FY2025, Pennant Group, Inc. had a net margin of 3.1% and a return on equity of 7.9%.
Is PNTG overvalued or undervalued?
Pennant Group, Inc. trades at about 45.7× trailing earnings — below its 10-year norm (10-year range 32.9×–240.0×, median 58.8×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for PNTG?
The average Wall-Street price target for Pennant Group, Inc. is $40.83, about 6.4% above the recent price, from 6 analysts (consensus: strong buy).
Is PNTG a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Pennant Group, Inc.: a Piotroski F-score of 3/9, an Altman Z″ in the grey zone, a P/E of about 42.2×, a dividend yield of 0.93%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.